Delivery Order SPE2DR25D1002-SPE2DR26FGJ2N
- Not listed
- The Defense Logistics Agency awarded a $19,295.10 delivery order to AmerisourceBergen Drug Corp for Orencia ClickJect 125 mg/ml, a biologic medication used primarily to treat rheumatoid arthritis and other autoimmune conditions. This competitively awarded, firm fixed-price contract with no set-aside designation was executed on September 3, 2025, with an ultimate completion date of September 4, 2025, indicating expedited fulfillment requirements. The product will be delivered to Conshohocken,...
- The Defense Logistics Agency awarded a $11,053.11 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Orencia ClickJect 125 mg/mL, a biologic medication used primarily for rheumatoid arthritis treatment. The contract, awarded on September 10, 2025, with an ultimate completion date of September 11, 2025, represents a non-competitive, non-set-aside delivery order executed through the company's existing DLA contract vehicle. AmerisourceBergen Drug Corp, headquartered in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $4,720.08 to AmerisourceBergen Drug Corp for Orencia Clickject 125 mg/mL, a biologic medication used to treat rheumatoid arthritis and other autoimmune conditions. The award was made on October 22, 2025, with an ultimate completion date of October 23, 2025, under firm fixed-price terms with no set-aside designation. The place of performance is AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania, where the...
- The Defense Logistics Agency awarded a $11,567.20 delivery order to AmerisourceBergen Drug Corp on October 14, 2025, for the supply of Orencia Clickject 125 mg/ml, a pharmaceutical product used in the treatment of rheumatoid arthritis and other inflammatory conditions. This competitively awarded, firm fixed-price contract is classified as a non-set-aside procurement and is scheduled for completion by October 15, 2025. The work will be performed at AmerisourceBergen's corporate office location in...
- The Defense Logistics Agency awarded a $5,061.00 delivery order to AmerisourceBergen Drug Corp for Orencia ClickJect 125 mg/mL, a biologic medication used to treat rheumatoid arthritis and other autoimmune conditions. This firm fixed price contract was awarded on July 8, 2025, with an ultimate completion date of July 9, 2025, and represents a non-set-aside competitive award. The delivery order is being fulfilled from AmerisourceBergen's location in Conshohocken, Pennsylvania, the company's...
- The Defense Logistics Agency awarded a $17,269.31 delivery order to AmerisourceBergen Drug Corp on September 23, 2025, for the supply of Orencia ClickJect 125 mg/ml, a biologic medication used primarily to treat rheumatoid arthritis and other autoimmune conditions. This firm fixed-price delivery order, with an ultimate completion date of September 24, 2025, will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The award utilized no set-aside designation and was...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 16, 2025, for the supply of Orencia ClickJect 125 mg/ml, a biologic medication used to treat rheumatoid arthritis and other autoimmune conditions. This firm fixed price delivery order is valued at $13,647.57 with an ultimate completion date of September 17, 2025. The contract carries no set-aside designation and was competitively awarded through the federal procurement process. The place of...
- The Defense Logistics Agency awarded a delivery order valued at $16,944.06 to AmerisourceBergen Drug Corp for the supply of Orencia ClickJect 125 mg/mL, a pharmaceutical product used in the treatment of rheumatoid arthritis. The contract, issued on September 5, 2025, with an ultimate completion date of September 8, 2025, utilizes firm fixed pricing and does not include a set-aside designation. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a delivery order valued at $8,105.46 to AmerisourceBergen Drug Corp for the supply of Orencia ClickJect 125 mg/mL, a biologic medication used to treat rheumatoid arthritis and other inflammatory conditions. This firm fixed-price delivery order was competitively awarded without set-aside designation and is scheduled for completion by April 28, 2025. The contract is being performed at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania....
- The Defense Logistics Agency awarded a delivery order valued at $26,393.22 to AmerisourceBergen Drug Corp for the supply of Orencia ClickJect 125 mg/ml, a pharmaceutical product used in the treatment of rheumatoid arthritis and other inflammatory conditions. This competitively awarded, firm fixed-price contract was issued on September 22, 2025, with an ultimate completion date of September 23, 2025, and represents a child order under a larger contract vehicle. The delivery is to be performed...
- SPE2DR25D1002Indefinite Delivery Contract
- SPE2DR25D1002-SPE2DR26FGJ2NDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $13,427.91 to AmerisourceBergen Drug Corp on October 31, 2025, for the supply of Orencia ClickJect 125 mg/mL, a biologic medication used to treat rheumatoid arthritis and other inflammatory conditions. This non-competitive, firm fixed-price delivery order is scheduled for completion by November 3, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a routine pharmaceutical procurement under the company's existing contract vehicle with DLA. This delivery order is issued under AmerisourceBergen's Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. As a major pharmaceutical distributor and critical federal medical vendor, AmerisourceBergen maintains a substantial portfolio of competitively-awarded contracts with the Defense Logistics Agency to supply comprehensive pharmaceutical products, medical devices, and healthcare commodities to support military and veteran healthcare systems. The company's role as a prime vendor enables flexible fulfillment of medical supply requirements across multiple therapeutic domains for the Defense Health Agency, U.S. Coast Guard, and other federal healthcare entities.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $13.4k | 10/31/25 |